A rare case of synchronous multiple primary lung cancer with different responses to gefitinib

Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.

Detalles Bibliográficos
Autores principales: Liao, Che-Chi, Lin, Yu-Sen, Lin, Yu-Chao, Cheng, Chiao-Jen, Chen, Shuo-Chueh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596341/
https://www.ncbi.nlm.nih.gov/pubmed/33145160
http://dx.doi.org/10.1016/j.rmcr.2020.101270
_version_ 1783602091858591744
author Liao, Che-Chi
Lin, Yu-Sen
Lin, Yu-Chao
Cheng, Chiao-Jen
Chen, Shuo-Chueh
author_facet Liao, Che-Chi
Lin, Yu-Sen
Lin, Yu-Chao
Cheng, Chiao-Jen
Chen, Shuo-Chueh
author_sort Liao, Che-Chi
collection PubMed
description Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.
format Online
Article
Text
id pubmed-7596341
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75963412020-11-02 A rare case of synchronous multiple primary lung cancer with different responses to gefitinib Liao, Che-Chi Lin, Yu-Sen Lin, Yu-Chao Cheng, Chiao-Jen Chen, Shuo-Chueh Respir Med Case Rep Case Report Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct. Elsevier 2020-10-24 /pmc/articles/PMC7596341/ /pubmed/33145160 http://dx.doi.org/10.1016/j.rmcr.2020.101270 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Liao, Che-Chi
Lin, Yu-Sen
Lin, Yu-Chao
Cheng, Chiao-Jen
Chen, Shuo-Chueh
A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
title A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
title_full A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
title_fullStr A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
title_full_unstemmed A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
title_short A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
title_sort rare case of synchronous multiple primary lung cancer with different responses to gefitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596341/
https://www.ncbi.nlm.nih.gov/pubmed/33145160
http://dx.doi.org/10.1016/j.rmcr.2020.101270
work_keys_str_mv AT liaochechi ararecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT linyusen ararecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT linyuchao ararecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT chengchiaojen ararecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT chenshuochueh ararecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT liaochechi rarecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT linyusen rarecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT linyuchao rarecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT chengchiaojen rarecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib
AT chenshuochueh rarecaseofsynchronousmultipleprimarylungcancerwithdifferentresponsestogefitinib

Ejemplares similares